Hikma Pharmaceuticals (LON:HIK – Free Report) had its price target boosted by Barclays from GBX 1,700 ($21.87) to GBX 1,800 ($23.16) in a research report sent to investors on Wednesday, MarketBeat Ratings reports. The brokerage currently has an equal weight rating on the stock. Separately, Jefferies Financial Group raised their target price on Hikma Pharmaceuticals […]
Hikma Pharmaceuticals (OTCMKTS:HKMPF – Free Report) had its price objective increased by Barclays from GBX 1,700 ($21.87) to GBX 1,800 ($23.16) in a research note issued to investors on Wednesday morning, FlyOnTheWall reports. Separately, Royal Bank of Canada increased their price objective on Hikma Pharmaceuticals from GBX 1,950 ($25.09) to GBX 2,050 ($26.37) in a […]
Barclays Raises Hikma Pharmaceuticals (LON:HIK) Price Target to GBX 1,800 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Hikma Pharmaceuticals (LON:HIK – Get Free Report) had its price objective hoisted by Barclays from GBX 1,700 ($21.87) to GBX 1,800 ($23.16) in a research report issued on Wednesday, Marketbeat.com reports. The firm presently has an “equal weight” rating on the stock. Barclays‘s target price indicates a potential downside of 1.13% from the company’s current […]
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 […]